You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
Antiretroviral therapy has improved the quality and length of life of millions of individuals affected by human immunodeficiency virus type 1 (HIV-1). The capacity of these drugs to indefinitely suppress HIV—which has a well-known capacity for escaping antiviral pressures—is surprising. In this issue of Science Translational Medicine, Shen et al. use a combination of mathematical modeling and experiment to examine the potency of anti-HIV drugs. They show that non-nucleoside reverse transcriptase inhibitors and protease inhibitors exhibit cooperative dose-response curves—a finding that has implications for the treatment of HIV as well as other viral infections, such as hepatitis C.
Footnotes
Citation: A. S. Perelson, S. G. Deeks, Drug Effectiveness Explained: The Mathematics of Antiviral Agents for HIV. Sci. Transl. Med. 3, 91ps30 (2011).
- Copyright © 2011, American Association for the Advancement of Science